Opinion: Europe’s lessons for the U.S. on how to cover weight loss drugs
It’s no secret that the obesity epidemic in the United States has reached alarming levels, with rates surpassing 40% of the population.
Despite a robust focus on wellness and exercise in the media, post-pandemic America continues to rank among the global leaders in obesity rates. Estimates indicate that treating obesity will be expensive, but those sums pale in comparison to the estimated direct and indirect costs of $1.7 trillion that obesity places on the U.S. health care system today. In 2018, research found that obesity is the No. 2 cause of preventable death in the United States.
Read Original Article: Opinion: Europe’s lessons for the U.S. on how to cover weight loss drugs »
